What does this research mean for the field?

Hematopoietic stem cell transplantation (HSCT) drastically improves survival and slows deterioration in patients with CSF1R-related disorder (CSF1R-RD). Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This research aims to evaluate the efficacy and safety of hematopoietic stem cell transplantation in treating CSF1R-related disorder.

March 1, 2026Open Access

Hematopoietic Stem Cell Transplantation for CSF1R-Related Disorder: A Longitudinal Study of Efficacy and Safety

Key Points

This research aims to evaluate the efficacy and safety of hematopoietic stem cell transplantation in treating CSF1R-related disorder.
Conducted a longitudinal study
Evaluated disease-modifying effects of HSCT
Measured survival rates and quality of life improvements
HSCT significantly improved survival rates
Quality of life was greatly preserved
Early intervention during the symptomatic phase is crucial

Abstract

HSCT is a potent disease-modifying therapy for CSF1R-RD, drastically improving survival and slowing deterioration. The findings underscore the necessity of early intervention during the symptomatic phase to maximize the preservation of quality of life for affected individuals.

Bookmark

View Full Paper

Bookmark

View Full Paper

Hematopoietic Stem Cell Transplantation for CSF1R-Related Disorder: A Longitudinal Study of Efficacy and Safety

Key Points

Abstract

Cite This Study